Alivus Life Sciences Limited (BOM:543322)
India
· Delayed Price · Currency is INR 1,013.00
-6.45 (-0.63%)
At close: Jul 11, 2025
Alivus Life Sciences Revenue
In the fiscal year ending March 31, 2025, Alivus Life Sciences had annual revenue of 23.87B INR with 4.54% growth. Alivus Life Sciences had revenue of 6.50B in the quarter ending March 31, 2025, with 21.05% growth.
Revenue
23.87B
Revenue Growth
+4.54%
P/S Ratio
5.41
Revenue / Employee
11.85M
Employees
2,014
Market Cap
129.20B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,561.48B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Hindustan Unilever | 631.21B |